116 related articles for article (PubMed ID: 16493598)
1. Identification of candidates for tumor-specific alternative splicing in the thyroid.
Guimarães GS; Latini FR; Camacho CP; Maciel RM; Dias-Neto E; Cerutti JM
Genes Chromosomes Cancer; 2006 Jun; 45(6):540-53. PubMed ID: 16493598
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
3. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer.
Wang Z; Lo HS; Yang H; Gere S; Hu Y; Buetow KH; Lee MP
Cancer Res; 2003 Feb; 63(3):655-7. PubMed ID: 12566310
[TBL] [Abstract][Full Text] [Related]
4. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas.
Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF
Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032
[TBL] [Abstract][Full Text] [Related]
6. Detection of alternative splice variants at the proteome level in Aspergillus flavus.
Chang KY; Georgianna DR; Heber S; Payne GA; Muddiman DC
J Proteome Res; 2010 Mar; 9(3):1209-17. PubMed ID: 20047314
[TBL] [Abstract][Full Text] [Related]
7. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.
Yoshida R; Numata K; Imoto S; Nagasaki M; Doi A; Ueno K; Miyano S
Genome Inform; 2006; 17(1):88-99. PubMed ID: 17503359
[TBL] [Abstract][Full Text] [Related]
8. Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis.
Xu JH; Wang YC; Geng X; Li YY; Zhang WM
Pathobiology; 2009; 76(1):23-9. PubMed ID: 19188747
[TBL] [Abstract][Full Text] [Related]
9. ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.
Lal G; Padmanabha L; Nicholson R; Smith BJ; Zhang L; Howe JR; Robinson RA; O'Dorisio MS
J Surg Res; 2008 Sep; 149(1):62-8. PubMed ID: 18374945
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
[TBL] [Abstract][Full Text] [Related]
11. A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours.
Lazzereschi D; Nardi F; Turco A; Ottini L; D'Amico C; Mariani-Costantini R; Gulino A; Coppa A
Oncogene; 2005 Aug; 24(34):5344-54. PubMed ID: 15940269
[TBL] [Abstract][Full Text] [Related]
12. Identification of alternative splicing markers for breast cancer.
Venables JP; Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Koh C; Gervais-Bird J; Lapointe E; Froehlich U; Durand M; Gendron D; Brosseau JP; Thibault P; Lucier JF; Tremblay K; Prinos P; Wellinger RJ; Chabot B; Rancourt C; Elela SA
Cancer Res; 2008 Nov; 68(22):9525-31. PubMed ID: 19010929
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
14. Investigation of tissue-specific human orthologous alternative splice events in pig.
Nygard AB; Jørgensen CB; Cirera S; Fredholm M
Anim Biotechnol; 2010 Oct; 21(4):203-16. PubMed ID: 20967640
[TBL] [Abstract][Full Text] [Related]
15. Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing.
Gupta S; Zink D; Korn B; Vingron M; Haas SA
BMC Genomics; 2004 Sep; 5():72. PubMed ID: 15453915
[TBL] [Abstract][Full Text] [Related]
16. Gene expression and isoform variation analysis using Affymetrix Exon Arrays.
Bemmo A; Benovoy D; Kwan T; Gaffney DJ; Jensen RV; Majewski J
BMC Genomics; 2008 Nov; 9():529. PubMed ID: 18990248
[TBL] [Abstract][Full Text] [Related]
17. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide detection of testis- and testicular cancer-specific alternative splicing.
He C; Zuo Z; Chen H; Zhang L; Zhou F; Cheng H; Zhou R
Carcinogenesis; 2007 Dec; 28(12):2484-90. PubMed ID: 17724370
[TBL] [Abstract][Full Text] [Related]
19. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome.
Hatakeyama K; Ohshima K; Fukuda Y; Ogura S; Terashima M; Yamaguchi K; Mochizuki T
Proteomics; 2011 Jun; 11(11):2275-82. PubMed ID: 21548097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
